Zurich Cantonal Bank
KERX

Zurich Cantonal Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Zurich Cantonal Bank’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,574
Closed -$26K – 2618
2018
Q3 		$26K Hold
7,574
– – ﹤0.01% 2425
2018
Q2 		$28K Hold
7,574
– – ﹤0.01% 2359
2018
Q1 		$31K Hold
7,574
– – ﹤0.01% 2292
2017
Q4 		$35K Buy
7,574
+4,289
+131% +$23.6K ﹤0.01% 2238
2017
Q3 		$23K Hold
3,285
– – ﹤0.01% 2223
2017
Q2 		$24K Hold
3,285
– – ﹤0.01% 2189
2017
Q1 		$20K Hold
3,285
– – ﹤0.01% 2311
2016
Q4 		$19K Hold
3,285
– – ﹤0.01% 2296
2016
Q3 		$17K Hold
3,285
– – ﹤0.01% 2290
2016
Q2 		$22K Hold
3,285
– – ﹤0.01% 2053
2016
Q1 		$15K Hold
3,285
– – ﹤0.01% 2224
2015
Q4 		$17K Buy
3,285
+2,063
+169% +$9.8K ﹤0.01% 2194
2015
Q3 		$4K Buy
1,222
+778
+175% +$5.21K ﹤0.01% 2425
2015
Q2 		$4K Hold
444
– – ﹤0.01% 2104
2015
Q1 		$6K Buy
+444
New +$5.71K ﹤0.01% 1815

Zurich Cantonal Bank's KERX Position: Q4 2018 in Review

Zurich Cantonal Bank sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 7,574 shares — an estimated $26K sold.

Zurich Cantonal Bank first reported a position in KERX in Q1 2015 and held it in 15 quarters. The position peaked at $35K in Q4 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Zurich Cantonal Bank reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Zurich Cantonal Bank sold 7,574 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $26K.
  • Zurich Cantonal Bank first reported a position in Keryx Biopharmaceuticals Inc in Q1 2015 and held it in 15 quarters.
  • Zurich Cantonal Bank's Keryx Biopharmaceuticals Inc position peaked at $35K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Zurich Cantonal Bank's 13F filing for Q4 2018, filed 25 Jan 2019.